Hosted on MSN9mon
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without PrescriptionTuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback